A Panoramic View of Market Authorisation in the EU

A Panoramic View of Market Authorisation in the EU

A Panoramic View of Market Authorisation in the EU

This year Partnerships in Clinical Trials Europe is bringing together clinical development outsourcing professionals to discuss “The era of change: A panoramic vision of reform, challenge and innovation in clinical trials.” With services that span Clinical Development, Late Stage Research and Safety, UBC is uniquely positioned to add our voice to the conversation. Our holistic approach to product development helps sponsors achieve and maintain market authorisation in Europe in three key areas:

Patient Recruitment Strategies that Work
Our Patient & Physician Services and clinical operations teams work closely to implement the most effective patient recruitment strategies for each study. Van Zyl Engelbrecht, Director, Clinical Research, will offer his insight during the Stream 3 session, “It’s all about the Patient: Patient Recruitment, Retention and becoming more Patient-Centric” at 15:10 on Wednesday, 18 November.

Real-World Evidence Generation that Proves Product Value
UBC has considerable expertise in collecting data in real-world conditions through Phase IV and post-marketing studies. These studies can demonstrate safety, effectiveness and value to regulators, payers, providers and patients. Click here to learn more about our Observational Study expertise.

A Proactive Approach to Safety
UBC’s safety experts leverage their experience interacting with the Pharmacovigilance and Risk Assessment Committee (PRAC) to ensure post-authorisation safety study (PASS) protocols are written to achieve approval with minimal delays. They put all of their secrets into a free whitepaper. Click here to download it now or stop by booth #318 to get your free copy.

Throughout the conference, our experts will be available in booth #318 to discuss these services or any of the other ways we can put your product on the path to successful commercialization. Stop by to meet them and enter to win an iPad mini.